治疗药物-话题@MedSci

#治疗药物#

300篇内容 | 2626人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1921807, encodeId=9919192180e61, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Br J Cancer：新型PPARγ激动剂CB11：非小细胞肺癌的潜在治疗药物, objectType=article, longId=201141, objectId=2fc5201141d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc5201141d5, replyNumber=0, likeNumber=83, createdTime=2021-06-09, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc5201141d5, moduleTitle=Br J Cancer：新型PPARγ激动剂CB11：非小细胞肺癌的潜在治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc5201141d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921800, encodeId=e1931921800e8, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单, objectType=article, longId=198997, objectId=e1ad19899eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ad19899eea, replyNumber=0, likeNumber=65, createdTime=2020-08-23, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ad19899eea, moduleTitle=国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ad19899eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921782, encodeId=ea3b1921e8268, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=有关KO血友病的药物问世：基因治疗药物Valrox有望上市, objectType=article, longId=189049, objectId=becc1890490e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=becc1890490e, replyNumber=0, likeNumber=88, createdTime=2021-01-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=becc1890490e, moduleTitle=有关KO血友病的药物问世：基因治疗药物Valrox有望上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=becc1890490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921797, encodeId=d1401921e970f, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072, objectType=article, longId=195529, objectId=cb091955294a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb091955294a, replyNumber=0, likeNumber=65, createdTime=2021-01-21, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb091955294a, moduleTitle=ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb091955294a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921765, encodeId=789a1921e6558, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=全新报告预测，2024年骨关节炎治疗药物市场规模将达到101亿美元, objectType=article, longId=181605, objectId=e2ae181605f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2ae181605f7, replyNumber=0, likeNumber=96, createdTime=2020-03-24, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2ae181605f7, moduleTitle=全新报告预测，2024年骨关节炎治疗药物市场规模将达到101亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2ae181605f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921796, encodeId=fd951921e96d3, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=FDA接受了全球早衰症治疗药物Zokinvy的新药申请, objectType=article, longId=194468, objectId=7cd8194468f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cd8194468f1, replyNumber=0, likeNumber=58, createdTime=2020-12-28, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cd8194468f1, moduleTitle=FDA接受了全球早衰症治疗药物Zokinvy的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cd8194468f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921775, encodeId=237f1921e75ce, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=中国乳腺癌靶向治疗药物安全性管理专家共识, objectType=article, longId=186230, objectId=e591186230cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e591186230cb, replyNumber=0, likeNumber=55, createdTime=2020-07-07, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e591186230cb, moduleTitle=中国乳腺癌靶向治疗药物安全性管理专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e591186230cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921774, encodeId=7cdb1921e74ff, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=国内！华大吉诺因肿瘤新生抗原细胞治疗药物获批临床，开启我国精准医疗新时代, objectType=article, longId=186053, objectId=1bf918605337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf918605337, replyNumber=0, likeNumber=87, createdTime=2020-11-12, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf918605337, moduleTitle=国内！华大吉诺因肿瘤新生抗原细胞治疗药物获批临床，开启我国精准医疗新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf918605337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921769, encodeId=05531921e6962, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=CDE发布了《突破性治疗药物工作程序》和《优先审评审批工作程序》征求意见, objectType=article, longId=182785, objectId=de68182e85f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de68182e85f1, replyNumber=0, likeNumber=78, createdTime=2020-03-07, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de68182e85f1, moduleTitle=CDE发布了《突破性治疗药物工作程序》和《优先审评审批工作程序》征求意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de68182e85f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921787, encodeId=6d6f1921e877b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=新型冠状病毒治疗药物和疫苗研发的新近进展, objectType=article, longId=191435, objectId=b5491914356d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5491914356d, replyNumber=0, likeNumber=72, createdTime=2020-07-11, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5491914356d, moduleTitle=新型冠状病毒治疗药物和疫苗研发的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5491914356d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921780, encodeId=20bc1921e8071, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市, objectType=article, longId=187927, objectId=1f1518e927fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f1518e927fe, replyNumber=0, likeNumber=70, createdTime=2020-10-30, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f1518e927fe, moduleTitle=国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f1518e927fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921766, encodeId=78d81921e6686, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=邱峰教授：肿瘤药物百花齐放，治疗药物监测保驾护航, objectType=article, longId=181758, objectId=5505181e58a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5505181e58a1, replyNumber=0, likeNumber=62, createdTime=2020-02-12, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5505181e58a1, moduleTitle=邱峰教授：肿瘤药物百花齐放，治疗药物监测保驾护航, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5505181e58a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921786, encodeId=d8271921e861c, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）, objectType=article, longId=191428, objectId=b8ab191428cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ab191428cc, replyNumber=0, likeNumber=91, createdTime=2021-01-16, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ab191428cc, moduleTitle=鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ab191428cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921792, encodeId=10231921e9284, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAMA超详细综述：盘点COVID-19治疗药物及临床试验进展, objectType=article, longId=192766, objectId=c70a192e66e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c70a192e66e8, replyNumber=0, likeNumber=76, createdTime=2020-11-28, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c70a192e66e8, moduleTitle=JAMA超详细综述：盘点COVID-19治疗药物及临床试验进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c70a192e66e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921777, encodeId=41a11921e7772, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=咯血的治疗药物选用及注意事项, objectType=article, longId=186567, objectId=bbad18656e38, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbad18656e38, replyNumber=0, likeNumber=71, createdTime=2020-03-18, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbad18656e38, moduleTitle=咯血的治疗药物选用及注意事项, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbad18656e38)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921776, encodeId=01b71921e762b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=骨代谢异常相关疼痛病的治疗药物与选用, objectType=article, longId=186562, objectId=13e618656244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13e618656244, replyNumber=0, likeNumber=100, createdTime=2020-09-10, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13e618656244, moduleTitle=骨代谢异常相关疼痛病的治疗药物与选用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13e618656244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921789, encodeId=de941921e89b5, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAMA综述：新冠病毒各类治疗药物进展，包括10款老药新用和3种辅助疗法, objectType=article, longId=192524, objectId=0986192524c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0986192524c8, replyNumber=0, likeNumber=80, createdTime=2020-12-06, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0986192524c8, moduleTitle=JAMA综述：新冠病毒各类治疗药物进展，包括10款老药新用和3种辅助疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0986192524c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921771, encodeId=83871921e71dd, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Keytruda获得欧盟的批准用于头颈癌的一线治疗药物, objectType=article, longId=183344, objectId=1575183344b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1575183344b0, replyNumber=0, likeNumber=67, createdTime=2020-02-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1575183344b0, moduleTitle=Keytruda获得欧盟的批准用于头颈癌的一线治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1575183344b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921778, encodeId=63f91921e7873, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Aimmune的Palforzia成为美国批准的**种花生过敏治疗药物, objectType=article, longId=187153, objectId=ed5018e153aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed5018e153aa, replyNumber=0, likeNumber=91, createdTime=2020-03-28, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed5018e153aa, moduleTitle=Aimmune的Palforzia成为美国批准的**种花生过敏治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed5018e153aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921773, encodeId=a1f01921e7327, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=默克的Keytruda成为美国批准用于治疗非肌肉浸润性膀胱癌的抗PD-1治疗药物, objectType=article, longId=185986, objectId=24e318598641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24e318598641, replyNumber=0, likeNumber=98, createdTime=2020-06-17, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24e318598641, moduleTitle=默克的Keytruda成为美国批准用于治疗非肌肉浸润性膀胱癌的抗PD-1治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24e318598641)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗药物

2020-05-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Br J Cancer：新型PPARγ激动剂CB11：非小细胞肺癌的潜在治疗药物

2021-06-09

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单

2020-08-23

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

有关KO血友病的药物问世：基因治疗药物Valrox有望上市

2021-01-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072

2021-01-21

柳叶一刀 (审核中...)

前往app查看评论内容

#治疗药物#

全新报告预测，2024年骨关节炎治疗药物市场规模将达到101亿美元

2020-03-24

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

FDA接受了全球早衰症治疗药物Zokinvy的新药申请

2020-12-28

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

中国乳腺癌靶向治疗药物安全性管理专家共识

2020-07-07

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

国内！华大吉诺因肿瘤新生抗原细胞治疗药物获批临床，开启我国精准医疗新时代

2020-11-12

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

CDE发布了《突破性治疗药物工作程序》和《优先审评审批工作程序》征求意见

2020-03-07

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

新型冠状病毒治疗药物和疫苗研发的新近进展

2020-07-11

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市

2020-10-30

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

邱峰教授：肿瘤药物百花齐放，治疗药物监测保驾护航

2020-02-12

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）

2021-01-16

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAMA超详细综述：盘点COVID-19治疗药物及临床试验进展

2020-11-28

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

咯血的治疗药物选用及注意事项

2020-03-18

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

骨代谢异常相关疼痛病的治疗药物与选用

2020-09-10

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAMA综述：新冠病毒各类治疗药物进展，包括10款老药新用和3种辅助疗法

2020-12-06

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Keytruda获得欧盟的批准用于头颈癌的一线治疗药物

2020-02-01

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Aimmune的Palforzia成为美国批准的**种花生过敏治疗药物

2020-03-28

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

默克的Keytruda成为美国批准用于治疗非肌肉浸润性膀胱癌的抗PD-1治疗药物

2020-06-17

科室
- - 订阅+
  - 更多科室
工具
服务